See the DrugPatentWatch profile for omnitrope
The cost of Omnitrope, a biosimilar to Genotropin, varies depending on factors such as dosage, insurance coverage, and pharmacy. Retail prices can range from several hundred to over a thousand dollars per vial, depending on the strength. For example, a 5 mg vial might cost approximately $600-$800 without insurance.
What influences the price of Omnitrope?
Several elements contribute to the final cost of Omnitrope. Insurance plans often have different formularies and co-pays, significantly impacting out-of-pocket expenses for patients. Pharmacies also set their own pricing, and discounts or patient assistance programs may be available, potentially lowering the cost [1].
How does Omnitrope's price compare to other growth hormone treatments?
As a biosimilar, Omnitrope is generally priced lower than the reference product, Genotropin, and other branded human growth hormones. This cost difference is a key characteristic of biosimilar medications, aiming to provide a more affordable treatment option for patients [2].
Where can I find potential savings for Omnitrope?
Patients may be eligible for savings through manufacturer coupons or patient assistance programs. Some pharmacies also offer discount cards or loyalty programs that can reduce the overall cost of the medication. Investigating these options can help mitigate the financial burden of treatment [1].
When do patents on growth hormone drugs expire?
The patent landscape for growth hormone drugs is complex, with multiple patents covering different aspects of the drug and its delivery. For biosimilars like Omnitrope to enter the market, they must navigate these patent protections. Information on specific patent expiry dates for growth hormone therapies can be found on resources like DrugPatentWatch.com [3].
Who manufactures Omnitrope?
Omnitrope is manufactured by Sandoz, a division of Novartis, which is a major player in the pharmaceutical industry, including the development of biosimilars [2].
What are the alternatives to Omnitrope for growth hormone deficiency?
Besides Omnitrope, other treatment options for growth hormone deficiency include other biosimilars and branded growth hormone products. The choice of treatment often depends on a combination of efficacy, cost, insurance coverage, and physician recommendation. These alternatives include Genotropin (somatropin-gcgc), Norditropin (somatropin-gptr), and Saizen (somatropin-aubu), among others [2].
*
**Sources:
[1] Information on drug pricing and patient assistance programs. (Accessed October 26, 2023).
[2] Sandoz. Omnitrope. (Accessed October 26, 2023).
[3] DrugPatentWatch.com. (Accessed October 26, 2023).